Literature DB >> 4928583

[Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].

D Larbaoui, P Chaulet, J Grosset, K Abderrahim, N Oussedik, C Coucke, L Benabdallah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4928583

Source DB:  PubMed          Journal:  Rev Tuberc Pneumol (Paris)        ISSN： 0035-1792


× No keyword cloud information.
  4 in total

Review 1.  Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review.

Authors:  M Zierski
Journal:  Lung       Date:  1977       Impact factor: 2.584

2.  Intermittent treatment regimens in pulmonary tuberculosis.

Authors:  M Zierski
Journal:  Lung       Date:  1979       Impact factor: 2.584

3.  Potentially serious side-effects of high-dose twice-weekly rifampicin.

Authors:  G Poole; P Stradling; S Worlledge
Journal:  Postgrad Med J       Date:  1971-11       Impact factor: 2.401

Review 4.  What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis.

Authors:  H R Stagg; R J Harris; H-A Hatherell; D Obach; H Zhao; N Tsuchiya; K Kranzer; V Nikolayevskyy; J Kim; M C Lipman; I Abubakar
Journal:  Thorax       Date:  2016-06-13       Impact factor: 9.139
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.